Geneva Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Geneva Advisors's ABBV Position: Q2 2017 in Review
Geneva Advisors reduced its AbbVie (ABBV) stake by 0.54% in Q2 2017, selling an estimated $18.4K and leaving 50,853 shares worth $3.69M. The position accounts for 0.06% of the portfolio, ranked #139.
Geneva Advisors first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. The position peaked at $79.6M in Q4 2014. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.
- Geneva Advisors held 50,853 shares of AbbVie worth $3.69M as of Q2 2017.
- Geneva Advisors sold 274 AbbVie shares in Q2 2017, an estimated $18.4K.
- AbbVie made up 0.06% of Geneva Advisors's portfolio in Q2 2017, its #139 holding.
- Geneva Advisors first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
- Geneva Advisors's AbbVie position peaked at $79.6M in Q4 2014.
- 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.